Ketamine and chronic treatment-resistant depression: real-world practice and after relapse.
BMC Psychiatry October 28, 2024 Sumaya Jobnah, Youssef Latifeh, Dina Al Kabani et al. 2 citations
Chronic treatment-resistant depression (TRD) poses a major challenge for clinicians. Ketamine has shown a rapid but short-lived antidepressant effect in several studies involving TRD patients with different demographic and clinical profiles. Our study aimed to assess the antidepressant effect of serial infusion sessions of ketamine in patients with chronic TRD and evaluate the severity of...